We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Xenetic Biosciences Inc is a biopharmaceutical company focused on progressing XCART, a personalized CAR T platform technology engineered to target patient-specific tumor neoantigens. The company is initially advancing cell-based therapeutics targeting B-cell receptor on the surface of an individual ... Xenetic Biosciences Inc is a biopharmaceutical company focused on progressing XCART, a personalized CAR T platform technology engineered to target patient-specific tumor neoantigens. The company is initially advancing cell-based therapeutics targeting B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. XCART has the potential to fuel a pipeline of therapeutic assets targeting oncology indications. It also has oncology therapeutic investigational drug candidate XBIO-101 for the treatment of progestin resistant endometrial cancer. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.2841 | -6.99753694581 | 4.06 | 4.3 | 3.74 | 2569 | 3.81090059 | CS |
4 | -0.0741 | -1.92467532468 | 3.85 | 4.74 | 3.74 | 6881 | 4.34082695 | CS |
12 | 0.1159 | 3.16666666667 | 3.66 | 4.74 | 3.3301 | 5747 | 4.16207633 | CS |
26 | 0.7159 | 23.3954248366 | 3.06 | 4.74 | 2.8696 | 5199 | 3.856826 | CS |
52 | -0.8451 | -18.2882492967 | 4.621 | 5.97 | 2.55 | 17122 | 3.64471512 | CS |
156 | -15.8241 | -80.7352040816 | 19.6 | 56.8 | 2.40101 | 941726 | 29.40496168 | CS |
260 | -10.5241 | -73.5951048951 | 14.3 | 168.895 | 2.40101 | 746185 | 26.49313664 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions